T cell receptor alpha variable 1-2 (TRAV1-2)

T cell receptor alpha variable 1-2 (TRAV1-2) is a gene segment encoding a variable region of the T cell receptor alpha (TCRα) chain, a critical component of the adaptive immune system. The TCR is a heterodimer, typically composed of an alpha chain (encoded in part by TRAV gene segments) and a beta chain, that recognizes peptide antigens presented by major histocompatibility complex (MHC) molecules on the surface of antigen-presenting cells[2][3]. TRAV1-2 is especially notable as the invariant alpha chain used by MAIT cells, a distinct subset of T cells that recognize microbial vitamin B metabolites presented by MR1 molecules rather than conventional peptide antigens[3]. These MAIT cells are important for antimicrobial immunity, particularly at mucosal surfaces. The TCR alpha and beta polypeptides are members of the immunoglobulin superfamily, mediate highly diverse antigen recognition, and transmit activation signals that are essential for T cell differentiation, activation, and the development of adaptive immune responses[2][3][5]. TRAV1-2 is not generally a direct drug target but represents a key genetic and functional marker for immunological studies, and an understanding of its usage is critical for research into MR1-restricted immunity, autoimmunity, tumor immunity, and T cell biology in health and disease.

Other names

TRAV1-2TCRAV1S2TCRAV7S2TRAV12

Not applicable; no drugs target TRAV1-2 specifically. Immunotherapies acting through the T cell response, such as checkpoint blockade (e.g., anti-PD1/PDL1, anti-CTLA4), can indirectly influence T cells expressing this receptor by modulating activation or proliferation thresholds of the T cell population as a whole[3].